AU533547B2 - Hydroxy pyrimidine derivatives and their use for the treatment of muscular dystrophies - Google Patents

Hydroxy pyrimidine derivatives and their use for the treatment of muscular dystrophies

Info

Publication number
AU533547B2
AU533547B2 AU56248/80A AU5624880A AU533547B2 AU 533547 B2 AU533547 B2 AU 533547B2 AU 56248/80 A AU56248/80 A AU 56248/80A AU 5624880 A AU5624880 A AU 5624880A AU 533547 B2 AU533547 B2 AU 533547B2
Authority
AU
Australia
Prior art keywords
treatment
pyrimidine derivatives
muscular dystrophies
hydroxy pyrimidine
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU56248/80A
Other languages
English (en)
Other versions
AU5624880A (en
Inventor
Andre Esanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D Etudes De Products Ste
Original Assignee
Societe dEtudes de Produits Chimiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU533547(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe dEtudes de Produits Chimiques SA filed Critical Societe dEtudes de Produits Chimiques SA
Publication of AU5624880A publication Critical patent/AU5624880A/en
Application granted granted Critical
Publication of AU533547B2 publication Critical patent/AU533547B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56248/80A 1979-03-10 1980-03-07 Hydroxy pyrimidine derivatives and their use for the treatment of muscular dystrophies Ceased AU533547B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7908494 1979-03-10
GB7914987 1979-04-30
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
AU5624880A AU5624880A (en) 1980-09-18
AU533547B2 true AU533547B2 (en) 1983-12-01

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56248/80A Ceased AU533547B2 (en) 1979-03-10 1980-03-07 Hydroxy pyrimidine derivatives and their use for the treatment of muscular dystrophies

Country Status (24)

Country Link
JP (1) JPS55122768A (ja)
AR (1) AR222691A1 (ja)
AU (1) AU533547B2 (ja)
BE (1) BE881752A (ja)
CA (1) CA1132561A (ja)
CH (1) CH644368A5 (ja)
DE (3) DE3009071C2 (ja)
EG (1) EG14282A (ja)
FI (1) FI66357C (ja)
FR (2) FR2451191A1 (ja)
GB (1) GB2045756B (ja)
HK (1) HK55383A (ja)
IE (1) IE49547B1 (ja)
IN (1) IN153791B (ja)
LU (1) LU82185A1 (ja)
MX (1) MX6218E (ja)
MY (1) MY8400200A (ja)
NL (1) NL184833C (ja)
NO (1) NO154054C (ja)
NZ (1) NZ192927A (ja)
OA (1) OA06484A (ja)
PT (1) PT70882A (ja)
SE (1) SE435180B (ja)
SG (1) SG22683G (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
IE49547B1 (en) 1985-10-30
FI66357C (fi) 1984-10-10
HK55383A (en) 1983-11-25
FI800566A (fi) 1980-09-11
GB2045756B (en) 1983-01-26
DE3009071A1 (de) 1980-09-11
EG14282A (en) 1983-09-30
NZ192927A (en) 1981-07-13
JPS55122768A (en) 1980-09-20
SE435180B (sv) 1984-09-10
DE3050999C2 (de) 1986-08-14
PT70882A (en) 1980-03-01
LU82185A1 (fr) 1980-06-06
DE3016752A1 (de) 1980-12-04
NL184468B (nl) 1989-03-01
IN153791B (ja) 1984-08-18
FR2451191A1 (fr) 1980-10-10
NO154054C (no) 1986-07-09
OA06484A (fr) 1981-07-31
SE8001812L (sv) 1980-09-11
NL184833C (nl) 1989-11-16
DE3050999A1 (ja) 1985-08-14
FR2451191B1 (ja) 1983-04-29
DE3009071C2 (de) 1985-11-14
SG22683G (en) 1983-12-16
NO800664L (no) 1980-09-11
FI66357B (fi) 1984-06-29
GB2045756A (en) 1980-11-05
FR2451370B1 (ja) 1983-05-13
CH644368A5 (en) 1984-07-31
MX6218E (es) 1984-12-21
FR2451370A1 (fr) 1980-10-10
NL184833B (nl) 1989-06-16
JPS6126996B2 (ja) 1986-06-23
AR222691A1 (es) 1981-06-15
AU5624880A (en) 1980-09-18
CA1132561A (en) 1982-09-28
DE3016752C2 (ja) 1987-06-25
IE800477L (en) 1980-09-10
NO154054B (no) 1986-04-01
NL8001289A (nl) 1980-09-12
MY8400200A (en) 1984-12-31
BE881752A (fr) 1980-05-30

Similar Documents

Publication Publication Date Title
DE3065181D1 (en) Cephalosporin derivatives, their preparation and their use
AU536388B2 (en) Hydromassage fitting
AU589371B2 (en) Purine derivatives and use as therapeutic agent
PH15719A (en) Aminoalkylbenzoic derivatives,pharmaceutical composition and method of use
IL60628A0 (en) Pyrimidinylurea derivatives and their use as herbicides
AU532506B2 (en) Sterilizer control and methods involving use thereof
ZM6780A1 (en) Preparations for the treatment of theileriosis and their use
AU528671B2 (en) Body fluid-purifying apparatus
AU533547B2 (en) Hydroxy pyrimidine derivatives and their use for the treatment of muscular dystrophies
AU3371278A (en) Treatment of printed surfaces
AU538641B2 (en) Treatment of cattle
PH16228A (en) Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use
IL64146A0 (en) Derivatives of thieno-pyridinone,the method of their preparation and their therapeutic use
JPS5663987A (en) Benzodiazepine compound and its use as medicine
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
AU535880B2 (en) 5h-furanone-2 and 3h-dihydrofuranone-2 derivatives
DE2861493D1 (en) Cephalosporin compounds and formulations containing them for use in the treatment of bacterial infections and the preparation of the cephalosporin compounds
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
AU547666B2 (en) 3-aminopropoxyphenyl derivatives and their use as pharmaceutical compounds
ZA783131B (en) New medicine useful for the treatment of bacterial affections
AU1982983A (en) Pyridyl-pyrimidone derivatives and their use as histamine h1-antagonists
AU526098B2 (en) Derivatives of clavulanic acid, their preparation and use
DE3061928D1 (en) 1-amino-2-propanol derivatives, process for their preparation and their therapeutic use
PT68553A (en) Clavulanic acid derivatives their preparation and use.
AU518489B2 (en) Thio-indazole derivatives and their use as antiinflammatory agents